Global PEGylated Proteins Supply, Demand and Key Producers, 2024-2030

Global PEGylated Proteins Supply, Demand and Key Producers, 2024-2030

Page: 105

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global PEGylated Proteins market size is expected to reach $ 4979.8 million by 2030, rising at a market growth of 3.6% CAGR during the forecast period (2024-2030).

The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.

PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.

This report studies the global PEGylated Proteins production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for PEGylated Proteins, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of PEGylated Proteins that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global PEGylated Proteins total production and demand, 2019-2030, (K MT)
Global PEGylated Proteins total production value, 2019-2030, (USD Million)
Global PEGylated Proteins production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K MT)
Global PEGylated Proteins consumption by region & country, CAGR, 2019-2030 & (K MT)
U.S. VS China: PEGylated Proteins domestic production, consumption, key domestic manufacturers and share
Global PEGylated Proteins production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K MT)
Global PEGylated Proteins production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K MT)
Global PEGylated Proteins production by Application production, value, CAGR, 2019-2030, (USD Million) & (K MT).

This reports profiles key players in the global PEGylated Proteins market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ENZON Pharmaceuticals, Merck Sharp & Dohme, Roche, Pfizer, Amgen, UCB and Crealta (Savient), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PEGylated Proteins market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global PEGylated Proteins Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global PEGylated Proteins Market, Segmentation by Type
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibodies
Others

Global PEGylated Proteins Market, Segmentation by Application
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn's Disease
Others

Companies Profiled:
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)

Key Questions Answered
1. How big is the global PEGylated Proteins market?
2. What is the demand of the global PEGylated Proteins market?
3. What is the year over year growth of the global PEGylated Proteins market?
4. What is the production and production value of the global PEGylated Proteins market?
5. Who are the key producers in the global PEGylated Proteins market?
btl

Table of Contents

1 Supply Summary
1.1 PEGylated Proteins Introduction
1.2 World PEGylated Proteins Supply & Forecast
1.2.1 World PEGylated Proteins Production Value (2019 & 2023 & 2030)
1.2.2 World PEGylated Proteins Production (2019-2030)
1.2.3 World PEGylated Proteins Pricing Trends (2019-2030)
1.3 World PEGylated Proteins Production by Region (Based on Production Site)
1.3.1 World PEGylated Proteins Production Value by Region (2019-2030)
1.3.2 World PEGylated Proteins Production by Region (2019-2030)
1.3.3 World PEGylated Proteins Average Price by Region (2019-2030)
1.3.4 North America PEGylated Proteins Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 PEGylated Proteins Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PEGylated Proteins Major Market Trends

2 Demand Summary
2.1 World PEGylated Proteins Demand (2019-2030)
2.2 World PEGylated Proteins Consumption by Region
2.2.1 World PEGylated Proteins Consumption by Region (2019-2024)
2.2.2 World PEGylated Proteins Consumption Forecast by Region (2025-2030)
2.3 United States PEGylated Proteins Consumption (2019-2030)
2.4 China PEGylated Proteins Consumption (2019-2030)
2.5 Europe PEGylated Proteins Consumption (2019-2030)
2.6 Japan PEGylated Proteins Consumption (2019-2030)
2.7 South Korea PEGylated Proteins Consumption (2019-2030)
2.8 ASEAN PEGylated Proteins Consumption (2019-2030)
2.9 India PEGylated Proteins Consumption (2019-2030)

3 World PEGylated Proteins Manufacturers Competitive Analysis
3.1 World PEGylated Proteins Production Value by Manufacturer (2019-2024)
3.2 World PEGylated Proteins Production by Manufacturer (2019-2024)
3.3 World PEGylated Proteins Average Price by Manufacturer (2019-2024)
3.4 PEGylated Proteins Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PEGylated Proteins Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PEGylated Proteins in 2023
3.5.3 Global Concentration Ratios (CR8) for PEGylated Proteins in 2023
3.6 PEGylated Proteins Market: Overall Company Footprint Analysis
3.6.1 PEGylated Proteins Market: Region Footprint
3.6.2 PEGylated Proteins Market: Company Product Type Footprint
3.6.3 PEGylated Proteins Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: PEGylated Proteins Production Value Comparison
4.1.1 United States VS China: PEGylated Proteins Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: PEGylated Proteins Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: PEGylated Proteins Production Comparison
4.2.1 United States VS China: PEGylated Proteins Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: PEGylated Proteins Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: PEGylated Proteins Consumption Comparison
4.3.1 United States VS China: PEGylated Proteins Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: PEGylated Proteins Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based PEGylated Proteins Manufacturers and Market Share, 2019-2024
4.4.1 United States Based PEGylated Proteins Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PEGylated Proteins Production Value (2019-2024)
4.4.3 United States Based Manufacturers PEGylated Proteins Production (2019-2024)
4.5 China Based PEGylated Proteins Manufacturers and Market Share
4.5.1 China Based PEGylated Proteins Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PEGylated Proteins Production Value (2019-2024)
4.5.3 China Based Manufacturers PEGylated Proteins Production (2019-2024)
4.6 Rest of World Based PEGylated Proteins Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based PEGylated Proteins Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PEGylated Proteins Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers PEGylated Proteins Production (2019-2024)

5 Market Analysis by Type
5.1 World PEGylated Proteins Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Colony Stimulating Factors
5.2.2 Interferons
5.2.3 Erythropoietin (EPO)
5.2.4 Recombinant Factor VIII
5.2.5 Monoclonal Antibodies
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World PEGylated Proteins Production by Type (2019-2030)
5.3.2 World PEGylated Proteins Production Value by Type (2019-2030)
5.3.3 World PEGylated Proteins Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World PEGylated Proteins Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cancer Treatment
6.2.2 Hepatitis
6.2.3 Chronic Kidney Disease
6.2.4 Leukemia
6.2.5 SCID
6.2.6 Rheumatoid Arthritis & Crohn's Disease
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World PEGylated Proteins Production by Application (2019-2030)
6.3.2 World PEGylated Proteins Production Value by Application (2019-2030)
6.3.3 World PEGylated Proteins Average Price by Application (2019-2030)

7 Company Profiles
7.1 ENZON Pharmaceuticals
7.1.1 ENZON Pharmaceuticals Details
7.1.2 ENZON Pharmaceuticals Major Business
7.1.3 ENZON Pharmaceuticals PEGylated Proteins Product and Services
7.1.4 ENZON Pharmaceuticals PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 ENZON Pharmaceuticals Recent Developments/Updates
7.1.6 ENZON Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Merck Sharp & Dohme
7.2.1 Merck Sharp & Dohme Details
7.2.2 Merck Sharp & Dohme Major Business
7.2.3 Merck Sharp & Dohme PEGylated Proteins Product and Services
7.2.4 Merck Sharp & Dohme PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Merck Sharp & Dohme Recent Developments/Updates
7.2.6 Merck Sharp & Dohme Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche PEGylated Proteins Product and Services
7.3.4 Roche PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer PEGylated Proteins Product and Services
7.4.4 Pfizer PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Amgen
7.5.1 Amgen Details
7.5.2 Amgen Major Business
7.5.3 Amgen PEGylated Proteins Product and Services
7.5.4 Amgen PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Amgen Recent Developments/Updates
7.5.6 Amgen Competitive Strengths & Weaknesses
7.6 UCB
7.6.1 UCB Details
7.6.2 UCB Major Business
7.6.3 UCB PEGylated Proteins Product and Services
7.6.4 UCB PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 UCB Recent Developments/Updates
7.6.6 UCB Competitive Strengths & Weaknesses
7.7 Crealta (Savient)
7.7.1 Crealta (Savient) Details
7.7.2 Crealta (Savient) Major Business
7.7.3 Crealta (Savient) PEGylated Proteins Product and Services
7.7.4 Crealta (Savient) PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Crealta (Savient) Recent Developments/Updates
7.7.6 Crealta (Savient) Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 PEGylated Proteins Industry Chain
8.2 PEGylated Proteins Upstream Analysis
8.2.1 PEGylated Proteins Core Raw Materials
8.2.2 Main Manufacturers of PEGylated Proteins Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 PEGylated Proteins Production Mode
8.6 PEGylated Proteins Procurement Model
8.7 PEGylated Proteins Industry Sales Model and Sales Channels
8.7.1 PEGylated Proteins Sales Model
8.7.2 PEGylated Proteins Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World PEGylated Proteins Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World PEGylated Proteins Production Value by Region (2019-2024) & (USD Million)
Table 3. World PEGylated Proteins Production Value by Region (2025-2030) & (USD Million)
Table 4. World PEGylated Proteins Production Value Market Share by Region (2019-2024)
Table 5. World PEGylated Proteins Production Value Market Share by Region (2025-2030)
Table 6. World PEGylated Proteins Production by Region (2019-2024) & (K MT)
Table 7. World PEGylated Proteins Production by Region (2025-2030) & (K MT)
Table 8. World PEGylated Proteins Production Market Share by Region (2019-2024)
Table 9. World PEGylated Proteins Production Market Share by Region (2025-2030)
Table 10. World PEGylated Proteins Average Price by Region (2019-2024) & (USD/MT)
Table 11. World PEGylated Proteins Average Price by Region (2025-2030) & (USD/MT)
Table 12. PEGylated Proteins Major Market Trends
Table 13. World PEGylated Proteins Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K MT)
Table 14. World PEGylated Proteins Consumption by Region (2019-2024) & (K MT)
Table 15. World PEGylated Proteins Consumption Forecast by Region (2025-2030) & (K MT)
Table 16. World PEGylated Proteins Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key PEGylated Proteins Producers in 2023
Table 18. World PEGylated Proteins Production by Manufacturer (2019-2024) & (K MT)
Table 19. Production Market Share of Key PEGylated Proteins Producers in 2023
Table 20. World PEGylated Proteins Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 21. Global PEGylated Proteins Company Evaluation Quadrant
Table 22. World PEGylated Proteins Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and PEGylated Proteins Production Site of Key Manufacturer
Table 24. PEGylated Proteins Market: Company Product Type Footprint
Table 25. PEGylated Proteins Market: Company Product Application Footprint
Table 26. PEGylated Proteins Competitive Factors
Table 27. PEGylated Proteins New Entrant and Capacity Expansion Plans
Table 28. PEGylated Proteins Mergers & Acquisitions Activity
Table 29. United States VS China PEGylated Proteins Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China PEGylated Proteins Production Comparison, (2019 & 2023 & 2030) & (K MT)
Table 31. United States VS China PEGylated Proteins Consumption Comparison, (2019 & 2023 & 2030) & (K MT)
Table 32. United States Based PEGylated Proteins Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PEGylated Proteins Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers PEGylated Proteins Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers PEGylated Proteins Production (2019-2024) & (K MT)
Table 36. United States Based Manufacturers PEGylated Proteins Production Market Share (2019-2024)
Table 37. China Based PEGylated Proteins Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PEGylated Proteins Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers PEGylated Proteins Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers PEGylated Proteins Production (2019-2024) & (K MT)
Table 41. China Based Manufacturers PEGylated Proteins Production Market Share (2019-2024)
Table 42. Rest of World Based PEGylated Proteins Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers PEGylated Proteins Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers PEGylated Proteins Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers PEGylated Proteins Production (2019-2024) & (K MT)
Table 46. Rest of World Based Manufacturers PEGylated Proteins Production Market Share (2019-2024)
Table 47. World PEGylated Proteins Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World PEGylated Proteins Production by Type (2019-2024) & (K MT)
Table 49. World PEGylated Proteins Production by Type (2025-2030) & (K MT)
Table 50. World PEGylated Proteins Production Value by Type (2019-2024) & (USD Million)
Table 51. World PEGylated Proteins Production Value by Type (2025-2030) & (USD Million)
Table 52. World PEGylated Proteins Average Price by Type (2019-2024) & (USD/MT)
Table 53. World PEGylated Proteins Average Price by Type (2025-2030) & (USD/MT)
Table 54. World PEGylated Proteins Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World PEGylated Proteins Production by Application (2019-2024) & (K MT)
Table 56. World PEGylated Proteins Production by Application (2025-2030) & (K MT)
Table 57. World PEGylated Proteins Production Value by Application (2019-2024) & (USD Million)
Table 58. World PEGylated Proteins Production Value by Application (2025-2030) & (USD Million)
Table 59. World PEGylated Proteins Average Price by Application (2019-2024) & (USD/MT)
Table 60. World PEGylated Proteins Average Price by Application (2025-2030) & (USD/MT)
Table 61. ENZON Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. ENZON Pharmaceuticals Major Business
Table 63. ENZON Pharmaceuticals PEGylated Proteins Product and Services
Table 64. ENZON Pharmaceuticals PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. ENZON Pharmaceuticals Recent Developments/Updates
Table 66. ENZON Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Merck Sharp & Dohme Basic Information, Manufacturing Base and Competitors
Table 68. Merck Sharp & Dohme Major Business
Table 69. Merck Sharp & Dohme PEGylated Proteins Product and Services
Table 70. Merck Sharp & Dohme PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Sharp & Dohme Recent Developments/Updates
Table 72. Merck Sharp & Dohme Competitive Strengths & Weaknesses
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche PEGylated Proteins Product and Services
Table 76. Roche PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Roche Recent Developments/Updates
Table 78. Roche Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer PEGylated Proteins Product and Services
Table 82. Pfizer PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Amgen Basic Information, Manufacturing Base and Competitors
Table 86. Amgen Major Business
Table 87. Amgen PEGylated Proteins Product and Services
Table 88. Amgen PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Amgen Recent Developments/Updates
Table 90. Amgen Competitive Strengths & Weaknesses
Table 91. UCB Basic Information, Manufacturing Base and Competitors
Table 92. UCB Major Business
Table 93. UCB PEGylated Proteins Product and Services
Table 94. UCB PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. UCB Recent Developments/Updates
Table 96. Crealta (Savient) Basic Information, Manufacturing Base and Competitors
Table 97. Crealta (Savient) Major Business
Table 98. Crealta (Savient) PEGylated Proteins Product and Services
Table 99. Crealta (Savient) PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 100. Global Key Players of PEGylated Proteins Upstream (Raw Materials)
Table 101. PEGylated Proteins Typical Customers
Table 102. PEGylated Proteins Typical Distributors
List of Figure
Figure 1. PEGylated Proteins Picture
Figure 2. World PEGylated Proteins Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World PEGylated Proteins Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World PEGylated Proteins Production (2019-2030) & (K MT)
Figure 5. World PEGylated Proteins Average Price (2019-2030) & (USD/MT)
Figure 6. World PEGylated Proteins Production Value Market Share by Region (2019-2030)
Figure 7. World PEGylated Proteins Production Market Share by Region (2019-2030)
Figure 8. North America PEGylated Proteins Production (2019-2030) & (K MT)
Figure 9. PEGylated Proteins Market Drivers
Figure 10. Factors Affecting Demand
Figure 11. World PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 12. World PEGylated Proteins Consumption Market Share by Region (2019-2030)
Figure 13. United States PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 14. China PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 15. Europe PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 16. Japan PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 17. South Korea PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 18. ASEAN PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 19. India PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 20. Producer Shipments of PEGylated Proteins by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 21. Global Four-firm Concentration Ratios (CR4) for PEGylated Proteins Markets in 2023
Figure 22. Global Four-firm Concentration Ratios (CR8) for PEGylated Proteins Markets in 2023
Figure 23. United States VS China: PEGylated Proteins Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 24. United States VS China: PEGylated Proteins Production Market Share Comparison (2019 & 2023 & 2030)
Figure 25. United States VS China: PEGylated Proteins Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 26. United States Based Manufacturers PEGylated Proteins Production Market Share 2023
Figure 27. China Based Manufacturers PEGylated Proteins Production Market Share 2023
Figure 28. Rest of World Based Manufacturers PEGylated Proteins Production Market Share 2023
Figure 29. World PEGylated Proteins Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World PEGylated Proteins Production Value Market Share by Type in 2023
Figure 31. Colony Stimulating Factors
Figure 32. Interferons
Figure 33. Erythropoietin (EPO)
Figure 34. Recombinant Factor VIII
Figure 35. Monoclonal Antibodies
Figure 36. Others
Figure 37. World PEGylated Proteins Production Market Share by Type (2019-2030)
Figure 38. World PEGylated Proteins Production Value Market Share by Type (2019-2030)
Figure 39. World PEGylated Proteins Average Price by Type (2019-2030) & (USD/MT)
Figure 40. World PEGylated Proteins Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World PEGylated Proteins Production Value Market Share by Application in 2023
Figure 42. Cancer Treatment
Figure 43. Hepatitis
Figure 44. Chronic Kidney Disease
Figure 45. Leukemia
Figure 46. SCID
Figure 47. Rheumatoid Arthritis & Crohn's Disease
Figure 48. Others
Figure 49. World PEGylated Proteins Production Market Share by Application (2019-2030)
Figure 50. World PEGylated Proteins Production Value Market Share by Application (2019-2030)
Figure 51. World PEGylated Proteins Average Price by Application (2019-2030) & (USD/MT)
Figure 52. PEGylated Proteins Industry Chain
Figure 53. PEGylated Proteins Procurement Model
Figure 54. PEGylated Proteins Sales Model
Figure 55. PEGylated Proteins Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global PEGylated Proteins Supply, Demand and Key Producers, 2024-2030

Global PEGylated Proteins Supply, Demand and Key Producers, 2024-2030

Page: 105

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global PEGylated Proteins market size is expected to reach $ 4979.8 million by 2030, rising at a market growth of 3.6% CAGR during the forecast period (2024-2030).

The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.

PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.

This report studies the global PEGylated Proteins production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for PEGylated Proteins, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of PEGylated Proteins that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global PEGylated Proteins total production and demand, 2019-2030, (K MT)
Global PEGylated Proteins total production value, 2019-2030, (USD Million)
Global PEGylated Proteins production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K MT)
Global PEGylated Proteins consumption by region & country, CAGR, 2019-2030 & (K MT)
U.S. VS China: PEGylated Proteins domestic production, consumption, key domestic manufacturers and share
Global PEGylated Proteins production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K MT)
Global PEGylated Proteins production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K MT)
Global PEGylated Proteins production by Application production, value, CAGR, 2019-2030, (USD Million) & (K MT).

This reports profiles key players in the global PEGylated Proteins market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ENZON Pharmaceuticals, Merck Sharp & Dohme, Roche, Pfizer, Amgen, UCB and Crealta (Savient), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PEGylated Proteins market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global PEGylated Proteins Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global PEGylated Proteins Market, Segmentation by Type
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibodies
Others

Global PEGylated Proteins Market, Segmentation by Application
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn's Disease
Others

Companies Profiled:
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)

Key Questions Answered
1. How big is the global PEGylated Proteins market?
2. What is the demand of the global PEGylated Proteins market?
3. What is the year over year growth of the global PEGylated Proteins market?
4. What is the production and production value of the global PEGylated Proteins market?
5. Who are the key producers in the global PEGylated Proteins market?
btl

Table of Contents

1 Supply Summary
1.1 PEGylated Proteins Introduction
1.2 World PEGylated Proteins Supply & Forecast
1.2.1 World PEGylated Proteins Production Value (2019 & 2023 & 2030)
1.2.2 World PEGylated Proteins Production (2019-2030)
1.2.3 World PEGylated Proteins Pricing Trends (2019-2030)
1.3 World PEGylated Proteins Production by Region (Based on Production Site)
1.3.1 World PEGylated Proteins Production Value by Region (2019-2030)
1.3.2 World PEGylated Proteins Production by Region (2019-2030)
1.3.3 World PEGylated Proteins Average Price by Region (2019-2030)
1.3.4 North America PEGylated Proteins Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 PEGylated Proteins Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PEGylated Proteins Major Market Trends

2 Demand Summary
2.1 World PEGylated Proteins Demand (2019-2030)
2.2 World PEGylated Proteins Consumption by Region
2.2.1 World PEGylated Proteins Consumption by Region (2019-2024)
2.2.2 World PEGylated Proteins Consumption Forecast by Region (2025-2030)
2.3 United States PEGylated Proteins Consumption (2019-2030)
2.4 China PEGylated Proteins Consumption (2019-2030)
2.5 Europe PEGylated Proteins Consumption (2019-2030)
2.6 Japan PEGylated Proteins Consumption (2019-2030)
2.7 South Korea PEGylated Proteins Consumption (2019-2030)
2.8 ASEAN PEGylated Proteins Consumption (2019-2030)
2.9 India PEGylated Proteins Consumption (2019-2030)

3 World PEGylated Proteins Manufacturers Competitive Analysis
3.1 World PEGylated Proteins Production Value by Manufacturer (2019-2024)
3.2 World PEGylated Proteins Production by Manufacturer (2019-2024)
3.3 World PEGylated Proteins Average Price by Manufacturer (2019-2024)
3.4 PEGylated Proteins Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PEGylated Proteins Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PEGylated Proteins in 2023
3.5.3 Global Concentration Ratios (CR8) for PEGylated Proteins in 2023
3.6 PEGylated Proteins Market: Overall Company Footprint Analysis
3.6.1 PEGylated Proteins Market: Region Footprint
3.6.2 PEGylated Proteins Market: Company Product Type Footprint
3.6.3 PEGylated Proteins Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: PEGylated Proteins Production Value Comparison
4.1.1 United States VS China: PEGylated Proteins Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: PEGylated Proteins Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: PEGylated Proteins Production Comparison
4.2.1 United States VS China: PEGylated Proteins Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: PEGylated Proteins Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: PEGylated Proteins Consumption Comparison
4.3.1 United States VS China: PEGylated Proteins Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: PEGylated Proteins Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based PEGylated Proteins Manufacturers and Market Share, 2019-2024
4.4.1 United States Based PEGylated Proteins Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PEGylated Proteins Production Value (2019-2024)
4.4.3 United States Based Manufacturers PEGylated Proteins Production (2019-2024)
4.5 China Based PEGylated Proteins Manufacturers and Market Share
4.5.1 China Based PEGylated Proteins Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PEGylated Proteins Production Value (2019-2024)
4.5.3 China Based Manufacturers PEGylated Proteins Production (2019-2024)
4.6 Rest of World Based PEGylated Proteins Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based PEGylated Proteins Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PEGylated Proteins Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers PEGylated Proteins Production (2019-2024)

5 Market Analysis by Type
5.1 World PEGylated Proteins Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Colony Stimulating Factors
5.2.2 Interferons
5.2.3 Erythropoietin (EPO)
5.2.4 Recombinant Factor VIII
5.2.5 Monoclonal Antibodies
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World PEGylated Proteins Production by Type (2019-2030)
5.3.2 World PEGylated Proteins Production Value by Type (2019-2030)
5.3.3 World PEGylated Proteins Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World PEGylated Proteins Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cancer Treatment
6.2.2 Hepatitis
6.2.3 Chronic Kidney Disease
6.2.4 Leukemia
6.2.5 SCID
6.2.6 Rheumatoid Arthritis & Crohn's Disease
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World PEGylated Proteins Production by Application (2019-2030)
6.3.2 World PEGylated Proteins Production Value by Application (2019-2030)
6.3.3 World PEGylated Proteins Average Price by Application (2019-2030)

7 Company Profiles
7.1 ENZON Pharmaceuticals
7.1.1 ENZON Pharmaceuticals Details
7.1.2 ENZON Pharmaceuticals Major Business
7.1.3 ENZON Pharmaceuticals PEGylated Proteins Product and Services
7.1.4 ENZON Pharmaceuticals PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 ENZON Pharmaceuticals Recent Developments/Updates
7.1.6 ENZON Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Merck Sharp & Dohme
7.2.1 Merck Sharp & Dohme Details
7.2.2 Merck Sharp & Dohme Major Business
7.2.3 Merck Sharp & Dohme PEGylated Proteins Product and Services
7.2.4 Merck Sharp & Dohme PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Merck Sharp & Dohme Recent Developments/Updates
7.2.6 Merck Sharp & Dohme Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche PEGylated Proteins Product and Services
7.3.4 Roche PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer PEGylated Proteins Product and Services
7.4.4 Pfizer PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Amgen
7.5.1 Amgen Details
7.5.2 Amgen Major Business
7.5.3 Amgen PEGylated Proteins Product and Services
7.5.4 Amgen PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Amgen Recent Developments/Updates
7.5.6 Amgen Competitive Strengths & Weaknesses
7.6 UCB
7.6.1 UCB Details
7.6.2 UCB Major Business
7.6.3 UCB PEGylated Proteins Product and Services
7.6.4 UCB PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 UCB Recent Developments/Updates
7.6.6 UCB Competitive Strengths & Weaknesses
7.7 Crealta (Savient)
7.7.1 Crealta (Savient) Details
7.7.2 Crealta (Savient) Major Business
7.7.3 Crealta (Savient) PEGylated Proteins Product and Services
7.7.4 Crealta (Savient) PEGylated Proteins Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Crealta (Savient) Recent Developments/Updates
7.7.6 Crealta (Savient) Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 PEGylated Proteins Industry Chain
8.2 PEGylated Proteins Upstream Analysis
8.2.1 PEGylated Proteins Core Raw Materials
8.2.2 Main Manufacturers of PEGylated Proteins Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 PEGylated Proteins Production Mode
8.6 PEGylated Proteins Procurement Model
8.7 PEGylated Proteins Industry Sales Model and Sales Channels
8.7.1 PEGylated Proteins Sales Model
8.7.2 PEGylated Proteins Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World PEGylated Proteins Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World PEGylated Proteins Production Value by Region (2019-2024) & (USD Million)
Table 3. World PEGylated Proteins Production Value by Region (2025-2030) & (USD Million)
Table 4. World PEGylated Proteins Production Value Market Share by Region (2019-2024)
Table 5. World PEGylated Proteins Production Value Market Share by Region (2025-2030)
Table 6. World PEGylated Proteins Production by Region (2019-2024) & (K MT)
Table 7. World PEGylated Proteins Production by Region (2025-2030) & (K MT)
Table 8. World PEGylated Proteins Production Market Share by Region (2019-2024)
Table 9. World PEGylated Proteins Production Market Share by Region (2025-2030)
Table 10. World PEGylated Proteins Average Price by Region (2019-2024) & (USD/MT)
Table 11. World PEGylated Proteins Average Price by Region (2025-2030) & (USD/MT)
Table 12. PEGylated Proteins Major Market Trends
Table 13. World PEGylated Proteins Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K MT)
Table 14. World PEGylated Proteins Consumption by Region (2019-2024) & (K MT)
Table 15. World PEGylated Proteins Consumption Forecast by Region (2025-2030) & (K MT)
Table 16. World PEGylated Proteins Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key PEGylated Proteins Producers in 2023
Table 18. World PEGylated Proteins Production by Manufacturer (2019-2024) & (K MT)
Table 19. Production Market Share of Key PEGylated Proteins Producers in 2023
Table 20. World PEGylated Proteins Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 21. Global PEGylated Proteins Company Evaluation Quadrant
Table 22. World PEGylated Proteins Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and PEGylated Proteins Production Site of Key Manufacturer
Table 24. PEGylated Proteins Market: Company Product Type Footprint
Table 25. PEGylated Proteins Market: Company Product Application Footprint
Table 26. PEGylated Proteins Competitive Factors
Table 27. PEGylated Proteins New Entrant and Capacity Expansion Plans
Table 28. PEGylated Proteins Mergers & Acquisitions Activity
Table 29. United States VS China PEGylated Proteins Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China PEGylated Proteins Production Comparison, (2019 & 2023 & 2030) & (K MT)
Table 31. United States VS China PEGylated Proteins Consumption Comparison, (2019 & 2023 & 2030) & (K MT)
Table 32. United States Based PEGylated Proteins Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PEGylated Proteins Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers PEGylated Proteins Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers PEGylated Proteins Production (2019-2024) & (K MT)
Table 36. United States Based Manufacturers PEGylated Proteins Production Market Share (2019-2024)
Table 37. China Based PEGylated Proteins Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PEGylated Proteins Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers PEGylated Proteins Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers PEGylated Proteins Production (2019-2024) & (K MT)
Table 41. China Based Manufacturers PEGylated Proteins Production Market Share (2019-2024)
Table 42. Rest of World Based PEGylated Proteins Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers PEGylated Proteins Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers PEGylated Proteins Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers PEGylated Proteins Production (2019-2024) & (K MT)
Table 46. Rest of World Based Manufacturers PEGylated Proteins Production Market Share (2019-2024)
Table 47. World PEGylated Proteins Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World PEGylated Proteins Production by Type (2019-2024) & (K MT)
Table 49. World PEGylated Proteins Production by Type (2025-2030) & (K MT)
Table 50. World PEGylated Proteins Production Value by Type (2019-2024) & (USD Million)
Table 51. World PEGylated Proteins Production Value by Type (2025-2030) & (USD Million)
Table 52. World PEGylated Proteins Average Price by Type (2019-2024) & (USD/MT)
Table 53. World PEGylated Proteins Average Price by Type (2025-2030) & (USD/MT)
Table 54. World PEGylated Proteins Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World PEGylated Proteins Production by Application (2019-2024) & (K MT)
Table 56. World PEGylated Proteins Production by Application (2025-2030) & (K MT)
Table 57. World PEGylated Proteins Production Value by Application (2019-2024) & (USD Million)
Table 58. World PEGylated Proteins Production Value by Application (2025-2030) & (USD Million)
Table 59. World PEGylated Proteins Average Price by Application (2019-2024) & (USD/MT)
Table 60. World PEGylated Proteins Average Price by Application (2025-2030) & (USD/MT)
Table 61. ENZON Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. ENZON Pharmaceuticals Major Business
Table 63. ENZON Pharmaceuticals PEGylated Proteins Product and Services
Table 64. ENZON Pharmaceuticals PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. ENZON Pharmaceuticals Recent Developments/Updates
Table 66. ENZON Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Merck Sharp & Dohme Basic Information, Manufacturing Base and Competitors
Table 68. Merck Sharp & Dohme Major Business
Table 69. Merck Sharp & Dohme PEGylated Proteins Product and Services
Table 70. Merck Sharp & Dohme PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Sharp & Dohme Recent Developments/Updates
Table 72. Merck Sharp & Dohme Competitive Strengths & Weaknesses
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche PEGylated Proteins Product and Services
Table 76. Roche PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Roche Recent Developments/Updates
Table 78. Roche Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer PEGylated Proteins Product and Services
Table 82. Pfizer PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Amgen Basic Information, Manufacturing Base and Competitors
Table 86. Amgen Major Business
Table 87. Amgen PEGylated Proteins Product and Services
Table 88. Amgen PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Amgen Recent Developments/Updates
Table 90. Amgen Competitive Strengths & Weaknesses
Table 91. UCB Basic Information, Manufacturing Base and Competitors
Table 92. UCB Major Business
Table 93. UCB PEGylated Proteins Product and Services
Table 94. UCB PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. UCB Recent Developments/Updates
Table 96. Crealta (Savient) Basic Information, Manufacturing Base and Competitors
Table 97. Crealta (Savient) Major Business
Table 98. Crealta (Savient) PEGylated Proteins Product and Services
Table 99. Crealta (Savient) PEGylated Proteins Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 100. Global Key Players of PEGylated Proteins Upstream (Raw Materials)
Table 101. PEGylated Proteins Typical Customers
Table 102. PEGylated Proteins Typical Distributors
List of Figure
Figure 1. PEGylated Proteins Picture
Figure 2. World PEGylated Proteins Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World PEGylated Proteins Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World PEGylated Proteins Production (2019-2030) & (K MT)
Figure 5. World PEGylated Proteins Average Price (2019-2030) & (USD/MT)
Figure 6. World PEGylated Proteins Production Value Market Share by Region (2019-2030)
Figure 7. World PEGylated Proteins Production Market Share by Region (2019-2030)
Figure 8. North America PEGylated Proteins Production (2019-2030) & (K MT)
Figure 9. PEGylated Proteins Market Drivers
Figure 10. Factors Affecting Demand
Figure 11. World PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 12. World PEGylated Proteins Consumption Market Share by Region (2019-2030)
Figure 13. United States PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 14. China PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 15. Europe PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 16. Japan PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 17. South Korea PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 18. ASEAN PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 19. India PEGylated Proteins Consumption (2019-2030) & (K MT)
Figure 20. Producer Shipments of PEGylated Proteins by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 21. Global Four-firm Concentration Ratios (CR4) for PEGylated Proteins Markets in 2023
Figure 22. Global Four-firm Concentration Ratios (CR8) for PEGylated Proteins Markets in 2023
Figure 23. United States VS China: PEGylated Proteins Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 24. United States VS China: PEGylated Proteins Production Market Share Comparison (2019 & 2023 & 2030)
Figure 25. United States VS China: PEGylated Proteins Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 26. United States Based Manufacturers PEGylated Proteins Production Market Share 2023
Figure 27. China Based Manufacturers PEGylated Proteins Production Market Share 2023
Figure 28. Rest of World Based Manufacturers PEGylated Proteins Production Market Share 2023
Figure 29. World PEGylated Proteins Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World PEGylated Proteins Production Value Market Share by Type in 2023
Figure 31. Colony Stimulating Factors
Figure 32. Interferons
Figure 33. Erythropoietin (EPO)
Figure 34. Recombinant Factor VIII
Figure 35. Monoclonal Antibodies
Figure 36. Others
Figure 37. World PEGylated Proteins Production Market Share by Type (2019-2030)
Figure 38. World PEGylated Proteins Production Value Market Share by Type (2019-2030)
Figure 39. World PEGylated Proteins Average Price by Type (2019-2030) & (USD/MT)
Figure 40. World PEGylated Proteins Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World PEGylated Proteins Production Value Market Share by Application in 2023
Figure 42. Cancer Treatment
Figure 43. Hepatitis
Figure 44. Chronic Kidney Disease
Figure 45. Leukemia
Figure 46. SCID
Figure 47. Rheumatoid Arthritis & Crohn's Disease
Figure 48. Others
Figure 49. World PEGylated Proteins Production Market Share by Application (2019-2030)
Figure 50. World PEGylated Proteins Production Value Market Share by Application (2019-2030)
Figure 51. World PEGylated Proteins Average Price by Application (2019-2030) & (USD/MT)
Figure 52. PEGylated Proteins Industry Chain
Figure 53. PEGylated Proteins Procurement Model
Figure 54. PEGylated Proteins Sales Model
Figure 55. PEGylated Proteins Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
jiaGou

Add To Cart

gouMai

Buy Now